Drug companies flock to supercharged T-cells in fight against autoimmune disease

AndyPR · Aug 5, 2017

Another article I thought interesting, so I'm sharing here with you guys. It doesn't mention ME.

Researchers in both academia and industry are turning to immune-suppressing cells to clamp down on autoimmune disorders, and the effort is building to a fever pitch.

On 24 July, pharmaceutical firm Eli Lilly of Indianapolis, Indiana, announced that it would pay up to US$400 million to support the development of a drug — which entered clinical trials in March — that stimulates these cells, called regulatory T cells. And in January, Celgene of Summit, New Jersey, announced plans to buy a company working on a similar therapy for $300 million.

Other companies, from tiny biotechs to pharmaceutical heavyweights, are also investing in an approach that could yield treatments for a variety of disorders caused by an immune attack on the body’s own cells. Such conditions include type 1 diabetes, lupus and rheumatoid arthritis.

“It’s a field that’s just, like, crazy,” says David Klatzmann, an immunologist at Pierre and Marie Curie University in Paris, who has been studying regulatory T cells and advises a Paris company called ILTOO Pharma. “The competition is coming very hard. It’s going to be exciting to see where it goes.”
Click to expand...

http://www.nature.com/news/drug-com...s-in-fight-against-autoimmune-disease-1.22393

Log in or Sign up

Drug companies flock to supercharged T-cells in fight against autoimmune disease

AndyPR Senior Member

See more popular forum discussions.

Share This Page

Log in or Sign up

Drug companies flock to supercharged T-cells in fight against autoimmune disease

AndyPR Senior Member

See more popular forum discussions.

Share This Page

Useful Searches